The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis
Mu-Hong Chen, Shu-Li Cheng, Yu-Chen Kao, Ping-Tao Tseng, Chih-Wei Hsu, Chia‐ling Yu, Fu-Chi Yang, Trevor Thompson, Tien-Wei Hsu, Chih-Sung Liang
Frontiers in Psychiatry August 13, 2024 DOI: 10.3389/fpsyt.2024.1439347 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review and Bayesian meta-analysis Peer reviewed |
|---|---|
| Sample size | 515 |
| Population | Adult patients with clinically diagnosed depression |
| Intervention | Psilocybin-assisted therapy |
| Topics | Psilocybin Psychedelic-assisted therapy |
| Keywords | Psychedelic-assisted treatment Mental health therapy Mood disorder treatment Bayesian meta-analysis Depressive symptoms Psilocybin-assisted therapy Psychotherapy outcome research |
| Citations | 8 |
| Key findings | The improvement of depressive symptoms was not associated with the type of psychological protocol in adult patients receiving psilocybin-assisted therapy. |
Abstract
Objective: Psilocybin-assisted therapy has shown promising efficacy on clinical depressive symptoms. However, diverse psychological support or psychotherapy was performed with psilocybin treatment. This study aimed to explore the association of psychological protocols with the efficacy of psilocybin-assisted therapy for depressive symptoms.
Method: Five major databases were systemic searched for clinical trials addressing psilocybin-assisted therapy for patients with clinical depressive symptoms. A Bayesian random-effects meta-analysis and meta-regression were performed. The effect size was mean difference (with 95% credible interval) measured by 17-Item Hamilton Depression Rating Scale.
Results: There were 10 eligible studies including 515 adult patients with clinically diagnosed depression. The psychological protocols could be categorized into four types: (i) manualized directive psychotherapy(k=1); (ii) manualized nondirective psychological support(k=3), (iii) non-manualized nondirective psychological support(k=5); and (iv) non-manualized supportive psychotherapy(k=1). The pooled standard mean difference of psilocybin-assisted therapy was 10.08 (5.03-14.70).
Conclusion: Compared with manualized nondirective psychological support, the other three psychological approaches did not differ significantly. The improvement of depressive symptoms was not associated with the psychological protocols in adult patients receiving psilocybin-assisted therapy. Systemic review registration Open Science Framework: identifier (osf.io/3YUDV).
Comparable studies
Other systematic reviews and meta-analyses on psilocybin and psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy | 2020 | Systematic review | |
| Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. Participants in studies of psychedelic therapy for depressive symptoms (Major... | 2023 | Systematic review with meta-analysis | n = 14 |
| Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. Patients diagnosed with life-threatening illnesses or major depressive disorder | 2023 | Systematic review and meta-analysis | n = 686 |
| United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020. | 2022 | Systematic review | |
| Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review. Human subjects in studies of psychedelic-assisted psychotherapy | 2024 | Systematic review and meta-analysis | n = 30 |
Citations in the library
Cited by 9
- Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond ACS Pharmacology & Translational Science March 7, 2025
- Should we skip the trip? Clinical implications of psychedelic-associated subjective effects and the potential role of non-hallucinogenic alternatives. General Hospital Psychiatry July 3, 2025
- The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis. Journal of Affective Disorders August 1, 2026
- Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin The British Journal of Psychiatry March 30, 2026
- Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus. Hearing research August 1, 2026
and 4 more in the library
Cites 23
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
and 18 more in the library